Association of posttraumatic stress disorder with increased prevalence of metabolic syndrome

Journal of Clinical Psychopharmacology

Volumn 29, Issue 3, 2009, Pages 210-215

  Jin, Hua ^a,b   Lanouette, Nicole M ^a   Mudaliar, Sunder ^b,c   Henry, Robert ^b,c   Folsom, David P ^a,d   Khandrika, Srikriskna ^a   Glorioso, Danielle K ^a,b   Jeste, Dilip V ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Department of Family and Preventive Medicine ^*

Author keywords

Metabolic syndrome; Psychotic disorders; PTSD

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; NEUROLEPTIC AGENT; OLANZAPINE; PSYCHOTROPIC AGENT;

ADULT; ADVERSE OUTCOME; AGED; ANAMNESIS; ARTICLE; BODY MASS; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; DEMENTIA; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MOOD DISORDER; PHYSICAL EXAMINATION; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; PRIORITY JOURNAL; SCHIZOPHRENIA; WAIST CIRCUMFERENCE;

ADULT; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL, HDL; CLINICAL TRIALS AS TOPIC; DEMENTIA; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MOOD DISORDERS; PREVALENCE; SCHIZOPHRENIA; STRESS DISORDERS, POST-TRAUMATIC; WAIST CIRCUMFERENCE;

EID: 67649259134     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181a45ed0     Document Type: Article

References (56)

1. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-689.
2. Alexander CM, Landsman PB, Teutsch SM, et al. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes. 2003;52:1210-1214.
3. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care. 2004;27:2444-2449.
4. Casey DE. Metabolic issues and cardiovascular disease in patients with psychiatric disorders. Am J Med. 2005;118(suppl 2):15S-22S.
5. McEvoy JP, Meyer JM, Goff DC, et al. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res. 2005;80:19-32.
6. Jakovljevic M, Crncevic Z, Ljubicic D, et al. Mental disorders and metabolic syndrome: a fatamorgana or warning reality? Psychiatr Danub. 2007;19:76-86.
7. Fagiolini A, Frank E, Scott JA, et al. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord. 2005;7:424-430.
8. Cardenas J, Frye MA, Marusak SL, et al. Modal subcomponents of metabolic syndrome in patients with bipolar disorder. J Affect Disord. 2008;106:91-97.
9. Heiskanen TH, Niskanen LK, Hintikka JJ, et al. Metabolic syndrome and depression: a cross-sectional analysis. J Clin Psychiatry. 2006;67:1422-1427.
10. Wirshing DA, Boyd JA, Meng LR, et al. The effects of novel antipsychotics on glucose and lipid levels. J Clin Psychiatry. 2002;63:856-865.
11. Jin H, Meyer JM, Jeste DV. Atypical antipsychotics and glucose dysregulation: a systematic review. Schizophr Res. 2004;71:195-212.
12. Butterfield MI, Becker ME, Connor KM, et al. Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol. 2001;16:197-203.
13. Hamner MB, Deitsch SE, Brodrick PS, et al. Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy. J Clin Psychopharmacol. 2003;23:15-20.
14. Petty F, Brannan S, Casada J, et al. Olanzapine treatment for post-traumatic stress disorder: an open-label study. Int Clin Psychopharmacol. 2001;16:331-337.
15. Stein MB, Kline NA, Matloff JL. Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. Am J Psychiatry. 2002;159:1777-1779.
16. Lambert MT. Aripiprazole in the management of post-traumatic stress disorder symptoms in returning Global War on Terrorism veterans. Int Clin Psychopharmacol. 2006;21:185-187.
17. Kozaric-Kovacic D. Psychopharmacotherapy of posttraumatic stress disorder. Croat Med J. 2008;49:459-475.
18. Jakovljevic M, Saric M, Nad S, et al. Metabolic syndrome, somatic and psychiatric comorbidity in war veterans with post-traumatic stress disorder: preliminary findings. Psychiatr Danub. 2006;18:169-176.
19. Violanti JM, Fekedulegn D, Hartley TA, et al. Police trauma and cardiovascular disease: association between PTSD symptoms and metabolic syndrome. Int J Emerg Ment Health. 2006;8:227-237.
20. Babic D, Jakovljevic M, Martinac M, et al. Metabolic syndrome and combat post-traumatic stress disorder intensity: preliminary findings. Psychiatr Danub. 2007;19:68-75.
21. David D, Woodward C, Esquenazi J, et al. Comparison of comorbid physical illnesses among veterans with PTSD and veterans with alcohol dependence. Psychiatr Serv. 2004;55:82-85.
22. Dobie DJ, Kivlahan DR, Maynard C, et al. Posttraumatic stress disorder in female veterans: association with self-reported health problems and functional impairment. Arch Intern Med. 2004;164:394-400.
23. Vieweg WV, Julius DA, Bates J, et al. Posttraumatic stress disorder as a risk factor for obesity among male military veterans. Acta Psychiatr Scand. 2007;116:483-487.
24. Vieweg WV, Julius DA, Fernandez A, et al. Posttraumatic stress disorder in male military veterans with comorbid overweight and obesity: psychotropic, antihypertensive, and metabolic medications. Prim Care Companion J Clin Psychiatry. 2006;8:25-31.
25. Maia DB, Marmar CR, Mendlowicz MV, et al. Abnormal serum lipid profile in Brazilian police officers with post-traumatic stress disorder. J Affect Disord. 2008;107:259-263.
26. Weisberg RB, Bruce SE, Machan JT, et al. Nonpsychiatric illness among primary care patients with trauma histories and posttraumatic stress disorder. Psychiatr Serv. 2002;53:848-854.
27. Goodwin RD, Davidson JR. Self-reported diabetes and posttraumatic stress disorder among adults in the community. Prev Med. 2005;40:570-574.
28. Trief PM, Ouimette P, Wade M, et al. Post-traumatic stress disorder and diabetes: co-morbidity and outcomes in a male veterans sample. J Behav Med. 2006;29:411-418.
29. Norman SB, Means-Christensen AJ, Craske MG, et al. Associations between psychological trauma and physical illness in primary care. J Trauma Stress. 2006;19:461-470.
30. Boscarino JA, Chang J. Electrocardiogram abnormalities among men with stress-related psychiatric disorders: implications for coronary heart disease and clinical research. Ann Behav Med. 1999;21:227-234.
31. Jeste DV, Blazer D, Casey DE, et al. ACNP White Paper: update on the use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology. 2008;33:957-970.
32. Salzman C, Jeste DV, Meyer RE, et al. Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy. J Clin Psychiatry. 2008;69:889-898.
33. Spitzer RL, Williams JB, Gibbon M, et al. Structured Clinical Interview for the DSM-IV. Washington, DC: American Psychiatric Association; 1994.
34. Miller MD, Paradis CF, Houck PR, et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale (CIRS). Psychiatry Res. 1992;41:237-248.
35. Brott T, Adams HP, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20:870.
36. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
37. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep. 1962;10:799-812.
38. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6:278-296.
39. Simpson GM, Angus JW. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl. 1970;212:11-19.
40. National Institute of Mental Health. Abnormal Involuntary Movement Scale (AIMS). Early Clinical Drug Evaluation Unit Intercom. 1975;4:3-6.
41. Folstein MF, Robins LN, Helzer JE. The Mini-Mental State Examination. Arch Gen Psychiatry. 1983;40:812.
42. Mattis S. Dementia Rating Scale. Odessa, FL: Psychological Assessment Resources, Inc; 1976.
43. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26:S5-S20.
44. Megnien JL, Denarie N, Cocaul M, et al. Predictive value of waist-to-hip ratio on cardiovascular risk events. Int J Obes Relat Metab Disord. 1999;23:90-98.
45. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227-239.
46. White H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica. 1980;48:817-830.
47. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale (BPRS): recent developments in ascertainment and scaling. Psychopharmacol Bull. 1988;24:97-99.
48. National Institutes of Health. Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (NCEP/ATP III): Executive Summary. Bethesda, MD: National Institute of Health; 2001. NIH publication no. 01-3670, 2008.
49. Hagg S, Soderberg S, Ahren B, et al. Leptin concentrations are increased in subjects treated with clozapine or conventional antipsychotics. J Clin Psychiatry. 2001;62:843-848.
50. Melkersson KI, Dahl ML. Relationship between levels of insulin or triglycerides and serum concentrations of the atypical antipsychotics clozapine and olanzapine in patients on treatment with therapeutic doses. Psychopharmacology. 2003;170:157-166.
51. Melkersson KI, Hulting AL. Insulin and leptin levels in patients with schizophrenia or related psychoses - a comparison between different antipsychotic agents. Psychopharmacology. 2001;154:205-212.
52. McEwen BS, Stellar E. Stress and the individual. Mechanisms leading to disease. Arch Intern Med. 1993;153:2093-2101.
53. McEwen BS. Mood disorders and allostatic load. Biol Psychiatry. 2003;54:200-207.
54. Blanchard EB, Kolb LC, Prins A. Psychophysiological responses in the diagnosis of posttraumatic stress disorder in Vietnam veterans. J Nerv Ment Dis. 1991;179:97-101.
55. Bjorntorp P. Do stress reactions cause abdominal obesity and comorbidities? Obes Rev. 2001;2:73-86.
56. Kyrou I, Chrousos GP, Tsigos C. Stress, visceral obesity, and metabolic complications. Ann N Y Acad Sci. 2006;1083:110.